Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patients accept artificial intelligence in skin cancer screening

Key clinical point: Most dermatology patients accepted the use of artificial intelligence (AI) for cancer screening but emphasized the need to maintain a human relationship with a physician.

Major finding: In all, 75% of patients said they would recommend an AI screening tool to a friend or family member, and 94% cited the value of symbiosis between AI and humans.

Study details: The data come from interviews with 48 patients seen at Brigham and Women’s Hospital and Dana Farber Cancer Center.

Disclosures: The authors disclosed financial relationships with pharmaceutical companies, government agencies, and nonprofit organizations.


Nelson CA et al. JAMA Dermatol. 2020 Mar 11. doi: 10.1001/jamadermatol.2019.5014; Kovarik CL. JAMA Dermatol. 2020 Mar 11. doi: 10.1001/jamadermatol.2019.5013.